Researchers and pharmacists have cautioned against the use of malaria drugs hydroxychloroquine and chloroquine for the treatment of COVID-19, warning against premature optimism that these drugs are effective and safe for use in COVID-19 patients.
As a result of the the pandemic we face, life-and-death choices will be made and often, artificial intelligence and machine learning can be used to make objective and informed recommendations. This editorial explores the challenges faced by healthcare systems, and how AI and machine learning can improve decision-making.
The results of a new study suggest that – compared with the general population – Ebola survivors may be at a significantly increased risk of death, particularly during the first year following hospital discharge.
New research has identified four novel sepsis phenotypes, suggesting these could be relevant for understanding the heterogeneity of treatment effects and help to explain recent clinical trial failures.
Long durations of antibiotic use in middle- and late-adulthood have been linked to an increased risk of cardiovascular events in new research studying over 36,000 women.
Research presented at ECCMID has highlighted large variations in mortality rate associated with different bloodstream infections, as well as the threat posed by these infections.
Find out more about the headlines from the Conference on Retroviruses and Opportunistic Infections 2019 (CROI) in our round-up of conference news.
In line with World AIDS Day this year we spoke to Andy Ustianowski (North Manchester General Hospital, UK) about the new challenges facing people living with HIV, including aging healthily and happily.
Financial modelling has been used to estimate the costs and likelihood of candidate medicines, vaccines, diagnostics and technologies launching, revealing gaps in the pipeline and in funding.
Clinical trial data has proved a novel, short therapy more effective and safe for the treatment of latent tuberculosis than the standard therapy in both adults and children.
